2019
DOI: 10.1177/1756286419838682
|View full text |Cite
|
Sign up to set email alerts
|

Radiomics: a novel feature extraction method for brain neuron degeneration disease using 18F-FDG PET imaging and its implementation for Alzheimer’s disease and mild cognitive impairment

Abstract: Background: Alzheimer’s disease (AD) is the most common form of progressive and irreversible dementia, and accurate diagnosis of AD at its prodromal stage is clinically important. Currently, computer-aided diagnosis of AD and mild cognitive impairment (MCI) using 18F-fluorodeoxy-glucose positron emission tomography (18F-FDG PET) imaging is usually based on low-level imaging features or deep learning methods, which have difficulties in achieving sufficient classification accuracy or lack clinical significance. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
46
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 49 publications
(47 citation statements)
references
References 35 publications
(95 reference statements)
1
46
0
Order By: Relevance
“…In the early years of radiomics, this new approach has been widely applied in oncology fields and has shown potential benefits for tumor grading and pathological classification (15,16). However, given its power in capturing the microstructural changes in tissues and its correlation with clinical endpoints (17) and age progression (18,19), the use of radiomics is expected to increase in neurodegenerative disorders (20). Presently, radiomics has been applied to the diagnosis of neurodegenerative diseases, including Alzheimer's disease (AD), amyotrophic lateral sclerosis, and Machado-Joseph disease with conventional MRI (21)(22)(23)(24)(25), which have similar pathological changes with PD, such as atrophy, abnormal proteins, or iron deposition in many brain regions.…”
Section: Introductionmentioning
confidence: 99%
“…In the early years of radiomics, this new approach has been widely applied in oncology fields and has shown potential benefits for tumor grading and pathological classification (15,16). However, given its power in capturing the microstructural changes in tissues and its correlation with clinical endpoints (17) and age progression (18,19), the use of radiomics is expected to increase in neurodegenerative disorders (20). Presently, radiomics has been applied to the diagnosis of neurodegenerative diseases, including Alzheimer's disease (AD), amyotrophic lateral sclerosis, and Machado-Joseph disease with conventional MRI (21)(22)(23)(24)(25), which have similar pathological changes with PD, such as atrophy, abnormal proteins, or iron deposition in many brain regions.…”
Section: Introductionmentioning
confidence: 99%
“…A study by Ashrafinia et al showed that ZSN extracted from 99m Tc-Sestamibi Myocardial-Perfusion SPECT (MPS) images showed high reproducibility [ 44 ]. Another recent study by Li et al on FDG PET radiomics analysis showed that ZSN is a stable feature [ 45 ]. The phantom repeatability and reproducibility study provides robust features for further radiomics modeling that has the potential to generalize to PET images reconstructed at other institutions where different reconstruction settings might have been applied.…”
Section: Discussionmentioning
confidence: 99%
“…A study by Ashrafinia et al showed that ZSN extracted from ⁹⁹ᵐTc-Sestamibi Myocardial-Perfusion SPECT (MPS) images showed high reproducibility [37]. Another recent study by Li et al on FDG PET radiomics analysis, showed that ZSN is a stable feature [38].…”
Section: Multivariate Analysismentioning
confidence: 99%